Are you providing fast and reliable detection platelet dysfunction?
The INNOVANCE® PFA-200 System provides automated assessment for inherited, acquired, or drug-induced platelet dysfunction. It measures the process of primary hemostasis and aids in the rapid detection of platelet dysfunction. Through flow technology, the system provides a realistic hemodynamic environment for the measurement of primary hemostasis.
Screens platelet function in patients with impaired primary hemostasis, such as von Willebrand disease
Provides excellent sensitivity for congenital platelet dysfunction, such as Glanzmann thrombasthenia
Verifies efficacy of desmopressin acetate (DDAVP) therapy in pre-surgical patients2
Assesses platelet dysfunction due to the effect of aspirin
Evaluates platelet dysfunction in multiple clinical settings, such as presurgical screening, high-risk pregnancy and menorrhagia
Detects platelet P2Y12-receptor blockades in patients undergoing therapy with P2Y12-receptor antagonists
Simple, rapid, qualitative, and precise automated assessment of platelet function
The INNOVANCE PFA-200 System provides simple, rapid, qualitative, and precise automated assessment of platelet function and supports clinically relevant decision-making processes effecting therapies. The system quickly measures platelet plug formation in a small whole blood sample (800 μL) and reports a ”closure time” in 5–8 minutes.
For full product information use the product website link below, or visit www.siemens.co.uk/diagnostics
Write a review
Sharing your experience will help scientists like you. Achieve Reviewer Status and Win an iPad 3 (All reviews published will be entered into the next drawing on January 30th 2014).